MedPath

University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu

Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Procedure: Metabolic Challenge Admission
Other: CGM home test
First Posted Date
2016-01-26
Last Posted Date
2019-07-23
Lead Sponsor
University of Virginia
Target Recruit Count
73
Registration Number
NCT02663661
Locations
🇺🇸

University of Virginia, Center for Diabetes Technology, Charlottesville, Virginia, United States

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Phase 1
Terminated
Conditions
Glioblastoma
Interventions
Radiation: Stereotactic Radiosurgery
First Posted Date
2016-01-07
Last Posted Date
2017-05-31
Lead Sponsor
University of Virginia
Target Recruit Count
4
Registration Number
NCT02648633
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome
Insulin Sensitivity
Interventions
Drug: Placebos
First Posted Date
2015-12-17
Last Posted Date
2020-03-23
Lead Sponsor
University of Virginia
Target Recruit Count
19
Registration Number
NCT02633488
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: 1-DAY ACUVUE® MOIST contact lenses
Device: 1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Other: No contact lenses
First Posted Date
2015-12-08
Last Posted Date
2020-03-06
Lead Sponsor
University of Virginia
Target Recruit Count
11
Registration Number
NCT02624791
Locations
🇺🇸

University of Virginia Driving Safety Lab, Charlottesville, Virginia, United States

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Phase 2
Terminated
Conditions
Solid Tumor
Brain Neoplasms
Childhood Solid Tumor
Non-Hodgkin Lymphoma
Rhabdomyosarcoma
Soft Tissue Sarcoma
Lymphoma
Childhood Lymphoma
Germ Cell Tumor
Wilms Tumor
Interventions
Drug: Placebo
First Posted Date
2015-12-08
Last Posted Date
2024-05-06
Lead Sponsor
University of Virginia
Target Recruit Count
4
Registration Number
NCT02624388
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia

Suspended
Conditions
Puberty
Polycystic Ovary Syndrome
Hyperandrogenism
Interventions
Other: Phenotype/genotype assessment
First Posted Date
2015-11-20
Last Posted Date
2023-11-02
Lead Sponsor
University of Virginia
Target Recruit Count
65
Registration Number
NCT02611128
Locations
🇺🇸

Center for Research in Reproduction, Charlottesville, Virginia, United States

Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP

Not Applicable
Active, not recruiting
Conditions
Bile Duct Diseases
Bile Duct Carcinoma
Choledocholithiasis
Interventions
Other: "Air" contrast cholangiography using carbon dioxide gas
First Posted Date
2015-11-20
Last Posted Date
2024-01-03
Lead Sponsor
University of Virginia
Target Recruit Count
40
Registration Number
NCT02611453
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Not Applicable
Conditions
Benign Prostatic Hyperplasia (BPH)
Prostatism
Prostatic Hypertrophy
Prostatic Hyperplasia
Lower Urinary Tract Symptoms (LUTS)
Hyperplasia
Male Urogenital Diseases
Genital Diseases, Male
Interventions
Device: Embozene Microspheres
First Posted Date
2015-10-30
Last Posted Date
2019-04-17
Lead Sponsor
University of Virginia
Target Recruit Count
50
Registration Number
NCT02592473
Locations
🇺🇸

University of Virginia Health Systems, Charlottesville, Virginia, United States

Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: beclomethasone
First Posted Date
2015-10-16
Last Posted Date
2018-10-25
Lead Sponsor
University of Virginia
Target Recruit Count
31
Registration Number
NCT02577497
Locations
🇺🇸

University of Virginia - Fontaine Research Park, Charlottesville, Virginia, United States

Effects Of Rehabilitation Incorporating Gait Training On Clinical Measures Associated With Chronic Ankle Instability

Phase 2
Completed
Conditions
Chronic Ankle Instability
Interventions
Other: Traditional Instability Tools
Other: Ankle Destabilization Shoes
First Posted Date
2015-08-26
Last Posted Date
2015-08-26
Lead Sponsor
University of Virginia
Target Recruit Count
26
Registration Number
NCT02533037
© Copyright 2025. All Rights Reserved by MedPath